详细信息

新型N^6-哌嗪取代腺苷衍生物的合成及其抗肿瘤活性    

Synthesis and Antitumor Activities of Novel N^6-Piperazine Substituted Adenosine Analogues

文献类型:期刊文献

中文题名:新型N^6-哌嗪取代腺苷衍生物的合成及其抗肿瘤活性

英文题名:Synthesis and Antitumor Activities of Novel N^6-Piperazine Substituted Adenosine Analogues

作者:周高辉[1];罗明明[1];张阳[1];于晓芹[1];陶黎明[1];徐文平[1]

机构:[1]华东理工大学药学院,上海200237

年份:2016

卷号:24

期号:4

起止页码:283

中文期刊名:合成化学

外文期刊名:Chinese Journal of Synthetic Chemistry

收录:CSTPCD;;CSCD:【CSCD_E2015_2016】;

基金:国家科技部支撑项目(2011BAE06B04)

语种:中文

中文关键词:哌嗪;腺苷衍生物;合成;Hela细胞;抗肿瘤活性

外文关键词:piperazine ; adenosine analogue ; synthesis ; Hela cells ; antitumor activitiy

摘要:以腺苷为母体,对其N6-位进行结构改造,首先经邻位双羟基保护,N6-位氯代,再在N6-位引入哌嗪环制得中间体2',3'-异丙叉-6-哌嗪嘌呤核苷(4);4与N-氯乙酰苯胺类似物(6a^6h)偶联后脱除邻位双羟基保护合成了8个新型的N6-哌嗪取代腺苷衍生物(8a^8h),其结构经1H NMR,13C NMR和HR-ESI-MS表征。采用MTT法研究了8a^8h对Hela肿瘤细胞的抑制活性。结果表明:大部分目标化合物对Hela肿瘤细胞具有较好的抑制活性,其中2-{4-[9-(3,4-二羟基-5-羟甲基-四氢呋喃-2-基)-9H-嘌呤-6-基]-哌嗪-1-基}-N-(3-氟苯基)-乙酰胺(8e)的活性最好,IC50为21.74μmol·L-1。
The intermediate, { ( 3R, 4R, 6R, 6R ) -2,2-dimethyl-6- [ 6- ( piperazin-1 -yl ) -9H-purin-9-yl ] tetrahydrofuro [ 3,4-d ] [ 1,3 ] dioxol-4-yl t methanol (4), was synthesized by three steps including adjacent hydroxyl protection, chlorination and introduction of piperazine at N^6 position, using adenosine as starting material. Eight novel N^6-piperazine substituted adenosine analogues (8a - 8h) were synthesized by coupling reaction of 4 with 6a - 6h, then deprotection of hydroxyl. The structures were characterized by ^1H NMR, ^13C NMR and HR-ESI-MS. Biological evaluation showed that 8a - 8h exhibited antitumor activities on Hela cells, especially, 2- { 4- [ 9- ( 3,4-dihydroxy-5-hydroxymethyl-tetrahydro-fu- ran-2-yl ) -9H-purin-6-yl ] -piperazin-1 -yl } -N- ( 3-fluoro-phenyl ) -acetamide ( 8e ) exhibited the strongest inhibitory activity with IC50 of 21.74 ixmol · L^-1.

参考文献:

正在载入数据...

版权所有©华东理工大学 重庆维普资讯有限公司 渝B2-20050021-7 
渝公网安备 50019002500408号 违法和不良信息举报中心